Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 5—May 2003

Research

Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis

Marianne L.L. van Genugten*Comments to Author , Marie-Louise A. Heijnen*, and Johannes C. Jager*
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table 6

Hospitalizations and deaths in various scenarios for alternative complication ratesa

Scenario No. of hospitalizations
No. of deaths
Base case Hospitalization and death rate
Base case Hospitalization and death rate
Age group <64 y x 2 Low risk to high risk rate Age group <64 y x 2 Low risk to high risk rate
Nonintervention
10,186
12,830
64,425
4,040
4,207
10,087
Influenza vaccination






Total population
3,847
4,376
16,798
1,738
1,771
3,981
Risk groups
3,968
4,617
50,935
1,789
1,873
5,333
Pneumococcal vaccination
7,008
8,857
58,597
3,903
4,066
9,950
Neuraminidase inhibitors 5,093 6,415 32,212 2,020 2,104 5,043

aSee Table 1.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO